Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Mutations01:39

Mutations

Overview
Point and Frameshift Mutations01:30

Point and Frameshift Mutations

Point mutations are genetic alterations involving the change of a single nucleotide base pair in DNA. Depending on how the alteration affects protein synthesis, they can lead to various consequences.Point mutations fall into the following types:Silent mutations occur when a nucleotide change does not alter the amino acid sequence due to the redundancy of the genetic code. For instance, changing ACC to ACA still encodes threonine, leaving the protein function unaffected. This occurs because...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2025 update of the National French consensus on gene lists for the diagnosis of muscle diseases using high-throughput sequencing.

Journal of neuromuscular diseases·2026
Same author

Autosomal Dominant Missense <i>DAG1</i> Variant Linked to Mild-Moderate LGMD R16.

Human mutation·2026
Same author

Risk factors for acquisition of SARS-CoV-2 Omicron variant among a prospective cohort of French Healthcare Workers: impact of hybrid immunity.

Scientific reports·2026
Same author

Conditioned accumbal dopamine transients forecast individual preference for drug versus natural rewards and compulsive behavior.

Nature neuroscience·2026
Same author

From eye to AI: Studying rodent social behavior in the era of machine learning.

Neuroscience and biobehavioral reviews·2026
Same author

Fragmentomics features of cell free DNA in eating disorders.

Translational psychiatry·2026

Related Experiment Video

Updated: Jun 27, 2026

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
07:44

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

The first missense mutation causing Rett syndrome specifically affecting the MeCP2_e1 isoform.

Yann Fichou1, Juliette Nectoux, Nadia Bahi-Buisson

  • 1Institut Cochin, Université Paris Descartes, CNRS (UMR 8104), Paris, France.

Neurogenetics
|November 27, 2008
PubMed
Summary

A novel mutation in the MeCP2_e1 gene causes severe Rett syndrome. This MeCP2_e1 deficiency impacts brain development, leading to significant cognitive and developmental impairments.

More Related Videos

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
08:27

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

Published on: May 22, 2019

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome
11:15

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Published on: March 2, 2018

Related Experiment Videos

Last Updated: Jun 27, 2026

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
07:44

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants

Published on: May 22, 2020

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
08:27

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

Published on: May 22, 2019

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome
11:15

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

Published on: March 2, 2018

Area of Science:

  • Genetics
  • Neuroscience
  • Molecular Biology

Background:

  • Rett syndrome is a neurodevelopmental disorder.
  • Mutations in the MECP2 gene are a primary cause of Rett syndrome.
  • The MeCP2_e1 isoform is brain-dominant and crucial for neurodevelopment.

Purpose of the Study:

  • To identify and characterize a novel de novo mutation in the MECP2 gene.
  • To evaluate the functional impact of the p.Ala2Val mutation on the MeCP2_e1 isoform.
  • To understand the role of MeCP2_e1 in Rett syndrome pathogenesis.

Main Methods:

  • Genetic sequencing to identify de novo mutations.
  • Cloning of wild-type and mutated MECP2_e1 cDNAs into expression vectors.
  • In vitro transfection of COS7 cells and analysis of protein localization.

Main Results:

  • Identified the first de novo mutation (p.Ala2Val) in the conserved N-terminal polyalanine stretch of MeCP2_e1.
  • The p.Ala2Val mutation leads to severe clinical symptoms including developmental delay and epilepsy.
  • In vitro studies confirmed nuclear localization of the mutant MeCP2_e1, similar to wild-type.
  • No impact on the MeCP2_e2 isoform was observed, suggesting MeCP2_e1's specific role.

Conclusions:

  • The N-terminus of MeCP2 is critical for its function.
  • MeCP2_e1 deficiency, specifically due to mutations like p.Ala2Val, significantly impacts intellectual processing and neurodevelopment.
  • This finding provides further evidence for the major role of MeCP2_e1 in Rett syndrome.